Sunshine Biopharma (Sunshine Biopharma) FCF Yield % : -188.39 (As of Jun. 24, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Sunshine Biopharma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Sunshine Biopharma's Trailing 12-Month Free Cash Flow is $0.00 Mil, and Market Cap is $0.00 Mil. Therefore, Sunshine Biopharma's FCF Yield % for today is -188.39%.

The historical rank and industry rank for Sunshine Biopharma's FCF Yield % or its related term are showing as below:

SBFMW' s FCF Yield % Range Over the Past 10 Years
Min: -594791.67 Med: -37.07 Max: -0.81
Current: -188.39

During the past 13 years, the highest FCF Yield % of Sunshine Biopharma was -0.81%. The lowest was -594791.67%. And the median was -37.07%.

SBFMW's FCF Yield % is ranked worse than
97.31% of 1080 companies
in the Drug Manufacturers industry
Industry Median: -0.155 vs SBFMW: -188.39

Sunshine Biopharma's FCF Margin % for the quarter that ended in Mar. 2024 was -51.52%.

Sunshine Biopharma FCF Yield % Historical Data

The historical data trend for Sunshine Biopharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunshine Biopharma FCF Yield % Chart

Sunshine Biopharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

Sunshine Biopharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Sunshine Biopharma's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Sunshine Biopharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sunshine Biopharma's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sunshine Biopharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Sunshine Biopharma's FCF Yield % falls into.

Sunshine Biopharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Sunshine Biopharma's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-9.563	/
	=	N/A%

Sunshine Biopharma's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-3.885	*	4	/
	=	N/A%

Sunshine Biopharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Sunshine Biopharma FCF Yield % Related Terms

Thank you for viewing the detailed overview of Sunshine Biopharma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sunshine Biopharma (Sunshine Biopharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sunshine Biopharma Inc (NAS:SBFMW) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

SBFM:USA

Address

6500 Trans-Canada Highway, 4th Floor, Pointe-Claire, QC, CAN, H9R 0A5

Website

https://www.sunshinebiopharma.com

Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug-Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5).